Illumina Inc (NASDAQ:ILMN)

CAPS Rating: 4 out of 5

The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.

Recs

0
Player Avatar JanBarleycorn (< 20) Submitted: 5/25/2011 2:03:10 AM : Outperform Start Price: $69.83 ILMN Score: -37.59

Good 3 Yr EPS & Revenue Growth.

Featured Broker Partners


Advertisement